A Deep Neural Network -- Mechanistic Hybrid Model to Predict
Pharmacokinetics in Rat
- URL: http://arxiv.org/abs/2310.09167v2
- Date: Tue, 2 Jan 2024 11:48:54 GMT
- Title: A Deep Neural Network -- Mechanistic Hybrid Model to Predict
Pharmacokinetics in Rat
- Authors: Florian F\"uhrer, Andrea Gruber, Holger Diedam, Andreas H. G\"oller,
Stephan Menz, Sebastian Schneckener
- Abstract summary: In this work we improve the hybrid model developed earlier.
We reduce the median fold change error for the total oral exposure from 2.85 to 2.35 and for intravenous administration from 1.95 to 1.62.
In contrast to a pure machine learning model, our model is able to predict new end points on which it has not been trained.
- Score: 0.0
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: An important aspect in the development of small molecules as drugs or
agro-chemicals is their systemic availability after intravenous and oral
administration. The prediction of the systemic availability from the chemical
structure of a potential candidate is highly desirable, as it allows to focus
the drug or agrochemical development on compounds with a favorable kinetic
profile. However, such pre-dictions are challenging as the availability is the
result of the complex interplay between molecular properties, biology and
physiology and training data is rare. In this work we improve the hybrid model
developed earlier [1]. We reduce the median fold change error for the total
oral exposure from 2.85 to 2.35 and for intravenous administration from 1.95 to
1.62. This is achieved by training on a larger data set, improving the neural
network architecture as well as the parametrization of mechanistic model.
Further, we extend our approach to predict additional endpoints and to handle
different covariates, like sex and dosage form. In contrast to a pure machine
learning model, our model is able to predict new end points on which it has not
been trained. We demonstrate this feature by predicting the exposure over the
first 24h, while the model has only been trained on the total exposure.
Related papers
- YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention [9.018408514318631]
Traditional solubility prediction techniques often fail to capture the complex nature of molecular tructures, leading to notable deviations between predictions and actual results.
This research introduces a novel deep learning framework combining attention-based transformers, Long Short-Term Memory (LSTM) networks, and Graph Convolutional Networks (GCN)
Our method achieved a correlation coefficient ($R2$) of 0.59 and a Root Mean Square Error (RMSE) of 0.57, which outperforms the benchmark models' scores of 0.52 ($R2$) and 0.61 (RMSE)
arXiv Detail & Related papers (2024-06-27T12:40:29Z) - Discovering intrinsic multi-compartment pharmacometric models using Physics Informed Neural Networks [0.0]
We introduce PKINNs, a novel purely data-driven neural network model.
PKINNs efficiently discovers and models intrinsic multi-compartment-based pharmacometric structures.
The resulting models are both interpretable and explainable through Symbolic Regression methods.
arXiv Detail & Related papers (2024-04-30T19:31:31Z) - Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
A major challenge for AI-driven drug discovery is the scarcity of high-quality data.
We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously.
Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
arXiv Detail & Related papers (2024-04-16T07:42:55Z) - MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data
Augmentation [58.93221876843639]
This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion.
It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space.
It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
arXiv Detail & Related papers (2023-10-04T01:36:30Z) - SAF: Smart Aggregation Framework for Revealing Atoms Importance Rank and
Improving Prediction Rates in Drug Discovery [0.0]
A successful approach for representing molecules is to treat them as a graph and utilize graph neural networks.
We propose a novel aggregating approach where each atom is weighted non-linearly using the Boltzmann distribution.
We show that using this weighted aggregation improves the ability of the gold standard message-passing neural network to predict antibiotic activity.
arXiv Detail & Related papers (2023-09-12T22:04:24Z) - Bi-level Contrastive Learning for Knowledge-Enhanced Molecule
Representations [55.42602325017405]
We propose a novel method called GODE, which takes into account the two-level structure of individual molecules.
By pre-training two graph neural networks (GNNs) on different graph structures, combined with contrastive learning, GODE fuses molecular structures with their corresponding knowledge graph substructures.
When fine-tuned across 11 chemical property tasks, our model outperforms existing benchmarks, registering an average ROC-AUC uplift of 13.8% for classification tasks and an average RMSE/MAE enhancement of 35.1% for regression tasks.
arXiv Detail & Related papers (2023-06-02T15:49:45Z) - Denoise Pretraining on Nonequilibrium Molecules for Accurate and
Transferable Neural Potentials [8.048439531116367]
We propose denoise pretraining on nonequilibrium molecular conformations to achieve more accurate and transferable GNN potential predictions.
Our models pretrained on small molecules demonstrate remarkable transferability, improving performance when fine-tuned on diverse molecular systems.
arXiv Detail & Related papers (2023-03-03T21:15:22Z) - Drug Synergistic Combinations Predictions via Large-Scale Pre-Training
and Graph Structure Learning [82.93806087715507]
Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation.
Deep learning models have emerged as an efficient way to discover synergistic combinations.
Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
arXiv Detail & Related papers (2023-01-14T15:07:43Z) - From Static to Dynamic Structures: Improving Binding Affinity Prediction
with a Graph-Based Deep Learning Model [33.92165575735532]
Accurate prediction of the protein-ligand binding affinities is an essential challenge in the structure-based drug design.
Here, we curated an MD dataset containing 3,218 different protein-ligand complexes, and developed Dynaformer, a graph-based deep learning model.
Dynaformer was able to accurately predict the binding affinities by learning the geometric characteristics of the protein-ligand interactions from the MD trajectories.
arXiv Detail & Related papers (2022-08-19T14:55:12Z) - Integrating Expert ODEs into Neural ODEs: Pharmacology and Disease
Progression [71.7560927415706]
latent hybridisation model (LHM) integrates a system of expert-designed ODEs with machine-learned Neural ODEs to fully describe the dynamics of the system.
We evaluate LHM on synthetic data as well as real-world intensive care data of COVID-19 patients.
arXiv Detail & Related papers (2021-06-05T11:42:45Z) - Explainable Deep Relational Networks for Predicting Compound-Protein
Affinities and Contacts [80.69440684790925]
DeepRelations is a physics-inspired deep relational network with intrinsically explainable architecture.
It shows superior interpretability to the state-of-the-art.
It boosts the AUPRC of contact prediction 9.5, 16.9, 19.3 and 5.7-fold for the test, compound-unique, protein-unique, and both-unique sets.
arXiv Detail & Related papers (2019-12-29T00:14:07Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.